Improvement in Severe Orthostatic Hypotension Following Carbidopa Dose Reduction

Can J Neurol Sci. 2018 Mar;45(2):252-253. doi: 10.1017/cjn.2017.284. Epub 2017 Dec 21.

Authors

Anthony C W Lau¹, John L Diggle², Penny P Bring³

Affiliations

¹ 1PharmacistDepartment of PharmacySurrey Memorial HospitalFraser Health Authority Surrey,BC,Canada.
² 2Neurologist and Regional Medical Director and HeadRegional Department of MedicineFraser Health AuthoritySurrey,BC,Canada.
³ 4Clinical Pharmacy Specialist NeurologyDepartment of PharmacySurrey Memorial HospitalFraser Health Authority Surrey, BC,Canada.

PMID: 29262877
DOI: 10.1017/cjn.2017.284

No abstract available

Keywords: Amino acid decarboxylase inhibitor; Carbidopa; Levodopa; Orthostatic hypotension; Parkinson’s disease.

Publication types

Case Reports
Letter

MeSH terms

Aged
Carbidopa / therapeutic use*
Dopamine Agents / therapeutic use*
Dose-Response Relationship, Drug
Female
Humans
Hypotension, Orthostatic / drug therapy*
Hypotension, Orthostatic / etiology*
Parkinson Disease / complications*
Parkinson Disease / drug therapy

Substances

Dopamine Agents
Carbidopa